BIOSYENT INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.1 CAD | +0.55% |
|
0.00% | -1.30% |
| May. 17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
| May. 17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on BioSyent Inc.
Price target over the last 5 years
History of analyst recommendation changes
4a355a9d1ddbb7da38eea325e.mChJOLaNTQms09jeLBe-RvYQ6DA7pwfdO_JuSv_FPfM.rUcnQv7cfErt4IeTGnPKEZJikVJ58Wm_Tb0-JLSVVrnxX39B0OYuWYGV6A~f3723263572022b92426a20d7481292d
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
9.1
CAD
Average target price
9.65
CAD
Spread / Average Target
+6.04%
High Price Target
9.65
CAD
Spread / Highest target
+6.04%
Low Price Target
9.65
CAD
Spread / Lowest Target
+6.04%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- RX Stock
- Consensus BioSyent Inc.
